* taking more "hard science" companies in YC (fusion, biotech, etc)
* taking later stage companies (Quora, others?)
* getting aggressive about scaling YC #s
I'm sure I'm missing some as well
* taking more "hard science" companies in YC (fusion, biotech, etc)
* taking later stage companies (Quora, others?)
* getting aggressive about scaling YC #s
I'm sure I'm missing some as well